Conference Coverage

Think methotrexate for granulomatous mastitis


 

EXPERT ANALYSIS FROM RWCS 2018

– Methotrexate is the most effective therapy for granulomatous mastitis, according to Anna Postolova, MD, a rheumatology fellow at Stanford (Calif.) University.

Granulomatous mastitis is a rare inflammatory disease of the breast of uncertain but possibly autoimmune etiology. The most common treatments – antibiotics, prednisone, and incision and drainage – are often ineffective and have a roughly 50% recurrence rate. That’s why Stanford rheumatologists began using methotrexate more than a decade ago with impressive results, she explained at the 2018 Rheumatology Winter Clinical Symposium.

mood shot for RWCS & GUILD conferenes Bruce Jancin/MDedge News
Presenting symptoms of granulomatous mastitis include unilateral or bilateral pain, palpable mass, redness, swelling, skin induration, erythema, abscess and/or fistula formation, and discharge. The differential diagnosis involves periductal mastitis, breast cancer, infection, sarcoidosis, and granulomatosis with polyangiitis. Diagnosis of granulomatous mastitis requires histologic examination of a biopsy specimen.

Pages

Recommended Reading

Biologic treatment in pregnancy requires balancing risks
MDedge ObGyn
Lupus may confer higher risk for cervical cancer
MDedge ObGyn
Early-onset preeclampsia more likely to occur in women with lupus
MDedge ObGyn
Low-dose cyclophosphamide unlikely to impair fertility in lupus patients
MDedge ObGyn
Prenatal exposure to hydroxychloroquine cuts risk of neonatal cutaneous lupus
MDedge ObGyn
Hypertension in SLE pregnancy: Is it lupus flare or preeclampsia?
MDedge ObGyn
Safety of corticosteroids in pregnancy: Is it the drug or the disease?
MDedge ObGyn
Study sheds light on pregnancy outcomes following ocrelizumab treatment
MDedge ObGyn
Health disparities in rural America: Chronic conditions
MDedge ObGyn
Hydroxychloroquine use rising in SLE pregnancies
MDedge ObGyn